首页> 外文OA文献 >A double chamber rotating bioreactor for enhanced tubular tissue generation from human mesenchymal stem cells
【2h】

A double chamber rotating bioreactor for enhanced tubular tissue generation from human mesenchymal stem cells

机译:双腔旋转生物反应器,用于增强人间充质干细胞产生的管状组织

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiovascular diseases represent a major global health burden, with high rates of mortality and morbidity. Autologous grafts are commonly used to replace damaged or failing blood vessels, however such approaches are hampered by the scarcity of suitable graft tissue, donor site morbidity and poor long-term stability. Tissue engineering has been investigated as a means by which exogenous vessel grafts can be produced, with varying levels of success to date, a result of mismatched mechanical properties of these vessel substitutes and inadequate ex vivo vessel tissue genesis. In this work, we describe the development of a novel multifunctional dual-phase (air/aqueous) bioreactor, designed to both rotate and perfuse small diameter tubular scaffolds and encourage enhanced tissue genesis throughout such scaffolds. Within this novel dynamic culture system, an elastomeric nanofibrous, microporous composite tubular scaffold, composed of Poly(caprolactone) and acrylated Poly(lactide-co-trimethylene-carbonate) and with mechanical properties approaching those of native vessels, was seeded with human mesenchymal stem cells and cultured for up to 14 days in inductive (smooth muscle) media. This scaffold/bioreactor combination provided a dynamic culture environment that enhanced (compared to static controls) scaffold colonisation, cell growth, extracellular matrix deposition, and in situ differentiation of the human mesenchymal stem cells into mature smooth muscle cells, representing a concrete step towards our goal of creating a mature ex vivo vascular tissue for implantation. This article is protected by copyright. All rights reserved.
机译:心血管疾病是全球主要的健康负担,死亡率和发病率很高。自体移植物通常用于替换受损或衰竭的血管,但是,此类方法因缺乏合适的移植物组织,供体部位发病率和长期稳定性差而受到阻碍。已经研究了组织工程学,作为可以生产外源性血管移植物的一种方法,迄今为止,成功的程度各不相同,这是这些血管替代物的机械性能不匹配以及离体血管组织发生不足的结果。在这项工作中,我们描述了新型多功能双相(空气/水)生物反应器的开发,该反应器旨在旋转和灌注小直径管状支架,并促进整个此类支架的组织发生。在这种新颖的动态培养系统中,用人间充质干细胞播种了一种弹性体纳米纤维,微孔复合管状支架,该支架由聚己内酯和丙烯酸化聚丙交酯-三亚甲基碳酸酯组成,其机械性能接近天然血管。细胞并在感应(平滑肌)培养基中培养长达14天。这种支架/生物反应器的组合提供了动态的培养环境,增强了(与静态对照相比)支架定植,细胞生长,细胞外基质沉积以及人间充质干细胞向成熟的平滑肌细胞的原位分化,这是迈向我们的具体步骤建立成熟的离体血管组织进行植入的目标。本文受版权保护。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号